Lorena Citterio

Lorena Citterio

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2010 in Nature
Verified
Journal Article
Open access
PDF file
HAHana Lango Allen
Hana Lango Allen
KEKarol Estrada
Karol Estrada
GLGuillaume Lettre
Guillaume Lettre
SBSonja I. Berndt
Sonja I. Berndt
MWMichael N. Weedon
Michael N. Weedon
JHJoel N. Hirschhorn
Joel N. Hirschhorn
A genome-wide association (GWA) study of more than 180,000 individuals has identified hundreds of genetic variants in at least 180 loci associated with adult human height. The loci are not clustered randomly but are enriched for genes involved in growth-related processes that influence adult height. This demonstrates that GWA studies of common human traits, and therefore of many diseases, can identify large numbers of loci that implicate potential causal genes. This very large genome-wide association study identifies hundreds of new genetic variants influencing adult height in at least 180 loci enriched for genes involved in skeletal growth defects. The results show that the likely causal gene is often located near the most strongly associated variant, that many loci have multiple independently associated variants and that associated variants are enriched for likely functional effects on genes. Most common human traits and diseases have a polygenic pattern of inheritance: DNA sequence variants at many genetic loci influence the phenotype. Genome-wide association (GWA) studies have identified more than 600 variants associated with human traits1, but these typically explain small fractions of phenotypic variation, raising questions about the use of further studies. Here, using 183,727 individuals, we show that hundreds of genetic variants, in at least 180 loci, influence adult height, a highly heritable and classic polygenic trait2,3. The large number of loci reveals patterns with important implications for genetic studies of common human diseases and traits. First, the 180 loci are not random, but instead are enriched for genes that are connected in biological pathways (P = 0.016) and that underlie skeletal growth defects (P < 0.001). Second, the likely causal gene is often located near the most strongly associated variant: in 13 of 21 loci containing a known skeletal growth gene, that gene was closest to the associated variant. Third, at least 19 loci have multiple independently associated variants, suggesting that allelic heterogeneity is a frequent feature of polygenic traits, that comprehensive explorations of already-discovered loci should discover additional variants and that an appreciable fraction of associated loci may have been identified. Fourth, associated variants are enriched for likely functional effects on genes, being over-represented among variants that alter amino-acid structure of proteins and expression levels of nearby genes. Our data explain approximately 10% of the phenotypic variation in height, and we estimate that unidentified common variants of similar effect sizes would increase this figure to approximately 16% of phenotypic variation (approximately 20% of heritable variation). Although additional approaches are needed to dissect the genetic architecture of polygenic human traits fully, our findings indicate that GWA studies can identify large numbers of loci that implicate biologically relevant genes and pathways.

1 May 1997 in The Lancet
Verified
Journal Article
Closed access
DCDaniele Cusi
Daniele Cusi
CBCristina Barlassina
Cristina Barlassina
TATiziana Azzani
Tiziana Azzani
GCGiorgio Casari
Giorgio Casari
LCLorena Citterio
Lorena Citterio
GBGiuseppe Bianchi
Giuseppe Bianchi

1 August 2013 in Cell
Verified
Journal Article
Open access
SASantosh S. Atanur
Santosh S. Atanur
ADAna Garcia Diaz
Ana Garcia Diaz
KMKlio Maratou
Klio Maratou
ASAllison Sarkis
Allison Sarkis
MRMaxime Rotival
Maxime Rotival
TATimothy J. Aitman
Timothy J. Aitman
Large numbers of inbred laboratory rat strains have been developed for a range of complex disease phenotypes. To gain insights into the evolutionary pressures underlying selection for these phenotypes, we sequenced the genomes of 27 rat strains, including 11 models of hypertension, diabetes, and insulin resistance, along with their respective control strains. Altogether, we identified more than 13 million single-nucleotide variants, indels, and structural variants across these rat strains. Analysis of strain-specific selective sweeps and gene clusters implicated genes and pathways involved in cation transport, angiotensin production, and regulators of oxidative stress in the development of cardiovascular disease phenotypes in rats. Many of the rat loci that we identified overlap with previously mapped loci for related traits in humans, indicating the presence of shared pathways underlying these phenotypes in rats and humans. These data represent a step change in resources available for evolutionary analysis of complex traits in disease models.

1 May 2003 in Diabetes
Verified
Journal Article
Closed access
PDF file
LMLucilla D. Monti
Lucilla D. Monti
CBCristina Barlassina
Cristina Barlassina
LCLorena Citterio
Lorena Citterio
EGElena Galluccio
Elena Galluccio
CBCarlo Berzuini
Carlo Berzuini
PPPierMarco Piatti
PierMarco Piatti
Endothelial nitric oxide synthase (eNOS) variants were previously demonstrated in cardiovascular disease. To evaluate whether eNOS gene variants are associated with insulin resistance and type 2 diabetes, we evaluated polymorphisms in Exon7 (E298D), intron 18 (IVS18 + 27A→C), and intron 23 (IVS23 + 10G→T) in 159 type 2 diabetic patients without macrovascular complications and in 207 healthy control subjects. Samples for all hormonal and metabolic variables were obtained after an overnight fast. The D298 and IVS18 + 27C alleles, but not the IVS23 + 10G→T variant, were significantly more frequent in type 2 diabetic patients than in control subjects. The two- and three-loci haplotype analysis showed that there is a statistically significant association between the eNOS variants and type 2 diabetes. No significant differences were observed in the clinical characteristics of type 2 diabetic patients according to genotypes (except for visceral obesity [waist-to-hip ratio], which was significantly more present in D298 homozygotes). Healthy control subjects homozygous for both D298 and IVS18 + 27C presented higher insulin, C-peptide, and nitric oxide levels, as well as higher HOMA (homeostasis model assessment) values than the double wild-type homozygotes, with values superimposable on those found in type 2 diabetic patients. In conclusion, we described a significant association between eNOS gene polymorphisms and type 2 diabetes, suggesting a new genetic susceptibility factor for hyperinsulinemia, insulin resistance, and type 2 diabetes.

1 June 1998 in Kidney International
Verified
Journal Article
Closed access
Paolo ManuntaPaolo Manunta
Paolo Manunta
DCDaniele Cusi
Daniele Cusi
CBCristina Barlassina
Cristina Barlassina
MRMarco Righetti
Marco Righetti
LCLanzani Chiara
Lanzani Chiara
GBGiuseppe Bianchi
Giuseppe Bianchi

1 August 2013 in Hypertension
Verified
Journal Article
Closed access
PDF file
STStephen T. Turner
Stephen T. Turner
EBEric Boerwinkle
Eric Boerwinkle
JOJeffrey R. O’connell
Jeffrey R. O’connell
KBKent R. Bailey
Kent R. Bailey
YGYan Gong
Yan Gong
JJJulie A. Johnson
Julie A. Johnson
To identify novel genes influencing blood pressure response to thiazide diuretic therapy for hypertension, we conducted genome-wide association meta-analyses of ≈1.1 million single-nucleotide polymorphisms in a combined sample of 424 European Americans with primary hypertension treated with hydrochlorothiazide from the Pharmacogenomic Evaluation of Antihypertensive Responses study (n=228) and the Genetic Epidemiology of Responses to Antihypertensive study (n=196). Polymorphisms associated with blood pressure response at P 4/4 mm Hg) across study samples. The rs2273359 polymorphism in the GNAS-EDN3 region also replicated for same-direction association with systolic blood pressure response in the Nordic Diltiazem study, and the combined 3-study meta-analysis P value approached genome-wide significance ( P =5.5×10 −8 ). The findings document clinically important effects of genetic variation at novel loci on blood pressure response to a thiazide diuretic, which may be a basis for individualization of antihypertensive drug therapy and identification of new drug targets.